Phase IV, open-label assessment of the treatment of actinic keratosis with 3.0% diclofenac sodium topical gel (Solaraze).

Christopher Nelson, Darrell Rigel, Stacy Smith, Neil Swanson, John Wolf

Research output: Contribution to journalArticlepeer-review

87 Scopus citations

Fingerprint

Dive into the research topics of 'Phase IV, open-label assessment of the treatment of actinic keratosis with 3.0% diclofenac sodium topical gel (Solaraze).'. Together they form a unique fingerprint.

Medicine & Life Sciences